Cypress Capital Management LLC acquired a new stake in Express Scripts Holding (NASDAQ:ESRX) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 3,667 shares of the company’s stock, valued at approximately $274,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Stonebridge Capital Advisors LLC lifted its stake in Express Scripts by 0.4% in the second quarter. Stonebridge Capital Advisors LLC now owns 24,059 shares of the company’s stock valued at $1,536,000 after buying an additional 100 shares during the last quarter. National Asset Management Inc. lifted its stake in Express Scripts by 1.5% in the second quarter. National Asset Management Inc. now owns 7,939 shares of the company’s stock valued at $510,000 after buying an additional 115 shares during the last quarter. San Francisco Sentry Investment Group CA lifted its stake in Express Scripts by 3.2% in the second quarter. San Francisco Sentry Investment Group CA now owns 4,487 shares of the company’s stock valued at $286,000 after buying an additional 138 shares during the last quarter. Westside Investment Management Inc. lifted its stake in Express Scripts by 2.5% in the second quarter. Westside Investment Management Inc. now owns 8,336 shares of the company’s stock valued at $515,000 after buying an additional 200 shares during the last quarter. Finally, Psagot Investment House Ltd. lifted its stake in Express Scripts by 1.2% in the second quarter. Psagot Investment House Ltd. now owns 27,528 shares of the company’s stock valued at $1,757,000 after buying an additional 327 shares during the last quarter. Institutional investors own 87.46% of the company’s stock.

In related news, VP Glen D. Stettin sold 3,448 shares of the company’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, VP Glen D. Stettin sold 3,449 shares of the company’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares in the company, valued at approximately $2,730,915. The disclosure for this sale can be found here. Insiders have sold 17,001 shares of company stock worth $1,249,505 in the last ninety days. 0.68% of the stock is currently owned by corporate insiders.

A number of equities research analysts have weighed in on the company. Mizuho set a $67.00 price objective on Express Scripts and gave the company a “hold” rating in a research note on Tuesday, October 24th. Sanford C. Bernstein cut Express Scripts from a “market perform” rating to an “underperform” rating and boosted their price objective for the company from $55.80 to $77.50 in a research note on Tuesday, January 30th. BidaskClub lowered Express Scripts from a “strong-buy” rating to a “buy” rating in a report on Friday, February 2nd. Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Finally, Royal Bank of Canada raised Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 target price on the stock in a report on Wednesday, January 31st. Six equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $78.23.

Express Scripts Holding (NASDAQ:ESRX) opened at $71.71 on Monday. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $83.49. The stock has a market capitalization of $40,614.61, a P/E ratio of 11.81, a PEG ratio of 0.77 and a beta of 0.93. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86.

Express Scripts declared that its Board of Directors has authorized a share buyback program on Monday, December 18th that allows the company to buyback 45,000,000 outstanding shares. This buyback authorization allows the company to buy shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

WARNING: “Cypress Capital Management LLC Takes Position in Express Scripts Holding (ESRX)” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.dailypolitical.com/2018/02/12/cypress-capital-management-llc-takes-position-in-express-scripts-holding-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.